{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:19:47Z","timestamp":1787667587659,"version":"build-2736575974"},"reference-count":61,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","award":["1912-03606"],"award-info":[{"award-number":["1912-03606"]}],"id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Aggregatibacter actinomycetemcomitans is a Gram-negative oral bacterium that has been primarily studied for its role in causing periodontal disease. The bacterium has also been implicated in several systemic diseases such as endocarditis and soft tissue abscesses. Leukotoxin (LtxA) is perhaps the best studied protein virulence factor from A. actinomycetemcomitans. The protein can rapidly destroy white blood cells (WBCs), helping the bacterium to subvert the host immune system. The functional receptor for LtxA is lymphocyte function associated antigen-1 (LFA-1), which is expressed exclusively on the surfaces of WBCs. Bacterial expression and secretion of the protein are highly regulated and controlled by a number of genetic and environmental factors. The mechanism of LtxA action on WBCs varies depending on the type of cell that is being killed, and the protein has been shown to activate numerous cell death pathways in susceptible cells. In addition to serving as an important virulence factor for the bacterium, because of its exquisite specificity and rapid activity, LtxA is also being investigated as a therapeutic agent that may be used to treat diseases such as hematological malignancies and autoimmune\/inflammatory diseases. It is our hope that this review will inspire an increased intensity of research related to LtxA and its effect on Aggressive Periodontitis, the disease that led to its initial discovery.<\/jats:p>","DOI":"10.3390\/pathogens13050354","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T03:23:47Z","timestamp":1714101827000},"page":"354","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Therapeutic Applications of Aggregatibacter actinomycetemcomitans Leukotoxin"],"prefix":"10.3390","volume":"13","author":[{"given":"Scott C.","family":"Kachlany","sequence":"first","affiliation":[{"name":"Department of Oral Biology, Rutgers School of Dental Medicine, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2346-181X","authenticated-orcid":false,"given":"Brian A.","family":"Vega","sequence":"additional","affiliation":[{"name":"Department of Oral Biology, Rutgers School of Dental Medicine, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(08)60135-X","article-title":"Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: A prospective longitudinal cohort study","volume":"371","author":"Haubek","year":"2008","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0006-291X(89)92431-5","article-title":"Identification and expression of the Actinobacillus actinomycetemcomitans leukotoxin gene","volume":"159","author":"Lally","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"30463","DOI":"10.1074\/jbc.272.48.30463","article-title":"RTX toxins recognize a beta2 integrin on the surface of human target cells","volume":"272","author":"Lally","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1242\/jcs.019117","article-title":"Integrins in immunity","volume":"122","author":"Evans","year":"2009","journal-title":"J. Cell Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1164\/ajrccm\/148.6_Pt_2.S55","article-title":"Control of leukocyte integrin activation","volume":"148","author":"Hogg","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-065X.2007.00537.x","article-title":"The role of the integrin LFA-1 in T-lymphocyte migration","volume":"218","author":"Smith","year":"2007","journal-title":"Immunol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/iai.25.1.427-439.1979","article-title":"Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism","volume":"25","author":"Tsai","year":"1979","journal-title":"Infect. Immun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1128\/iai.43.2.700-705.1984","article-title":"Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B","volume":"43","author":"Tsai","year":"1984","journal-title":"Infect. Immun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1128\/iai.47.1.31-36.1985","article-title":"Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans","volume":"47","author":"DiRienzo","year":"1985","journal-title":"Infect. Immun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0882-4010(91)90004-T","article-title":"Structure and function of the B and D genes of the Actinobacillus actinomycetemcomitans leukotoxin complex","volume":"11","author":"Lally","year":"1991","journal-title":"Microb. Pathog."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1128\/IAI.68.11.6094-6100.2000","article-title":"Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans","volume":"68","author":"Kachlany","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1046-5928(02)00037-2","article-title":"Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans","volume":"25","author":"Kachlany","year":"2002","journal-title":"Protein Expr. Purif."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1399-302X.1992.tb00015.x","article-title":"Electron immunocytochemical localization of Actinobacillus actinomycetemcomitans leukotoxin","volume":"7","author":"Berthold","year":"1992","journal-title":"Oral Microbiol. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/mpat.2001.0474","article-title":"Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin","volume":"32","author":"Kato","year":"2002","journal-title":"Microb. Pathog."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1128\/iai.59.12.4599-4605.1991","article-title":"Nuclease-sensitive binding of an Actinobacillus actinomycetemcomitans leukotoxin to the bacterial cell surface","volume":"59","author":"Ohta","year":"1991","journal-title":"Infect. Immun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imlet.2003.10.014","article-title":"How T cells use LFA-1 to attach and migrate","volume":"92","author":"Hogg","year":"2004","journal-title":"Immunol. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.2174\/138161206777947731","article-title":"LFA-1 as a key regulator of immune function: Approaches toward the development of LFA-1-based therapeutics","volume":"12","author":"Giblin","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1074\/jbc.M112417200","article-title":"Activation-induced conformational changes in the I domain region of lymphocyte function-associated antigen 1","volume":"277","author":"Ma","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1083\/jcb.116.6.1527","article-title":"Interaction of leukocyte integrins with ligand is necessary but not sufficient for function","volume":"116","author":"Dransfield","year":"1992","journal-title":"J. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1083\/jcb.116.1.219","article-title":"Divalent cation regulation of the function of the leukocyte integrin LFA-1","volume":"116","author":"Dransfield","year":"1992","journal-title":"J. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.4049\/jimmunol.168.12.6330","article-title":"Signaling through integrin LFA-1 leads to filamentous actin polymerization and remodeling, resulting in enhanced T cell adhesion","volume":"168","author":"Porter","year":"2002","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hioe, C.E., Tuen, M., Vasiliver-Shamis, G., Alvarez, Y., Prins, K.C., Banerjee, S., Nadas, A., Cho, M.W., Dustin, M.L., and Kachlany, S.C. (2011). HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA). PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023202"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.leukres.2009.08.022","article-title":"Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells","volume":"34","author":"Kachlany","year":"2010","journal-title":"Leuk. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17618","DOI":"10.1074\/jbc.M111.314674","article-title":"Leukotoxin (Leukothera(R)) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway","volume":"287","author":"DiFranco","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_25","first-page":"331","article-title":"Leukotoxin kills rodent WBC by targeting leukocyte function associated antigen 1","volume":"63","author":"DiFranco","year":"2013","journal-title":"Comp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1099\/mic.0.082347-0","article-title":"Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera) induces cofilin dephosphorylation and actin depolymerization during killing of malignant monocytes","volume":"160","author":"Kaur","year":"2014","journal-title":"Microbiology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.leukres.2015.03.010","article-title":"LFA-1-targeting Leukotoxin (LtxA; Leukothera(R)) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes","volume":"39","author":"DiFranco","year":"2015","journal-title":"Leuk. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/IAI.00309-19","article-title":"Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera(R)) requires death receptor Fas, in addition to LFA-1, to trigger cell death in T lymphocytes","volume":"87","author":"Vega","year":"2019","journal-title":"Infect. Immun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"18086","DOI":"10.1038\/s41598-021-97545-4","article-title":"Leukotoxin (LtxA\/Leukothera) induces ATP expulsion via pannexin-1 channels and subsequent cell death in malignant lymphocytes","volume":"11","author":"Prince","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/intimm\/6.6.831","article-title":"Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb","volume":"6","author":"Hasegawa","year":"1994","journal-title":"Int. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0049-0172(96)80034-5","article-title":"Adhesion molecules in autoimmune disease","volume":"25","author":"McMurray","year":"1996","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2169\/internalmedicine.42.947","article-title":"Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 protein and messenger RNA in primary biliary cirrhosis","volume":"42","author":"Yokomori","year":"2003","journal-title":"Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/clin.1994.1130","article-title":"Treatment of murine lupus with monoclonal antibodies to lymphocyte function-associated antigen-1: Dose-dependent inhibition of autoantibody production and blockade of the immune response to therapy","volume":"72","author":"Connolly","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1212\/WNL.51.6.1703","article-title":"Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS","volume":"51","author":"Elovaara","year":"1998","journal-title":"Neurology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00702-005-0409-y","article-title":"Molecular mechanisms involved in T cell migration across the blood-brain barrier","volume":"113","author":"Engelhardt","year":"2006","journal-title":"J. Neural Transm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2249.1994.tb06019.x","article-title":"Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes","volume":"95","author":"Thomson","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10001","article-title":"Inhibition of LFA-1\/ICAM-1 and VLA-4\/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases","volume":"22","author":"Anderson","year":"2002","journal-title":"Med. Res. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Aureli, A., Marziani, B., Venditti, A., Sconocchia, T., and Sconocchia, G. (2023). Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond. Cancers, 15.","DOI":"10.20944\/preprints202305.0620.v1"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MOH.0000000000000797","article-title":"Disparities in acute myeloid leukemia treatments and outcomes","volume":"31","author":"Eisfeld","year":"2024","journal-title":"Curr. Opin. Hematol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clml.2023.09.009","article-title":"Overall Survival in Patients with Multiple Myeloma in the U.S.: A Systematic Literature Review of Racial Disparities","volume":"24","author":"Mikhael","year":"2024","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_41","first-page":"e41660","article-title":"A Review of Hodgkin Lymphoma in the Era of Checkpoint Inhibitors","volume":"15","author":"Schimmoeller","year":"2023","journal-title":"Cureus"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7241\/ourd.20234.21","article-title":"Diet, sleep, and exercise in inflammatory skin diseases","volume":"14","author":"Afvari","year":"2023","journal-title":"Our Dermatol. Online"},{"key":"ref_43","first-page":"e47006","article-title":"The Current Advancement in Psoriasis","volume":"15","author":"Bhagwat","year":"2023","journal-title":"Cureus"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40272-023-00592-9","article-title":"Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies","volume":"26","author":"Lie","year":"2024","journal-title":"Paediatr. Drugs"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Reali, E., and Ferrari, D. (2023). From the Skin to Distant Sites: T Cells in Psoriatic Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115707"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/jid.2011.161","article-title":"Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model","volume":"131","author":"Stenderup","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaci.2021.11.012","article-title":"2021 year in review: Spotlight on eosinophils","volume":"149","author":"Dunn","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4168\/aair.2013.5.4.189","article-title":"Immunopathogenesis of allergic asthma: More than the th2 hypothesis","volume":"5","author":"Kim","year":"2013","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e046519","DOI":"10.1136\/bmjopen-2020-046519","article-title":"House dust mite (HDM) and storage mite (SM) molecular sensitisation profiles and association with clinical outcomes in allergic asthma and rhinitis: Protocol for a systematic review","volume":"11","author":"Cruz","year":"2021","journal-title":"BMJ Open"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"104770","DOI":"10.1016\/j.cellimm.2023.104770","article-title":"Early-immune development in asthma: A review of the literature","volume":"393","author":"Medeleanu","year":"2023","journal-title":"Cell. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pop.2016.04.006","article-title":"Respiratory Allergic Disorders","volume":"43","author":"Woloski","year":"2016","journal-title":"Prim. Care"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1189\/jlb.5HI0414-196R","article-title":"Expression and targeting of lymphocyte function-associated antigen 1 (LFA-1) on white blood cells for treatment of allergic asthma","volume":"97","author":"Gupta","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/BTT.S380027","article-title":"A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances","volume":"16","author":"Abdulla","year":"2022","journal-title":"Biol. Targets Ther."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Imbrizi, M., Magro, F., and Coy, C.S.R. (2023). Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years. Pharmaceuticals, 16.","DOI":"10.3390\/ph16091272"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101672","DOI":"10.1016\/j.disamonth.2023.101672","article-title":"Factors influencing the quality of life in inflammatory bowel disease: A comprehensive review","volume":"70","author":"Khan","year":"2023","journal-title":"Dis. Mon."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Mihai, I.R., Burlui, A.M., Rezus, I.I., Mihai, C., Macovei, L.A., Cardoneanu, A., Gavrilescu, O., Dranga, M., and Rezus, E. (2023). Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-alpha Treatment-A Review. Life, 13.","DOI":"10.3390\/life13081779"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.dld.2022.12.024","article-title":"Management of inflammatory bowel disease in the elderly: A review","volume":"55","author":"Sousa","year":"2023","journal-title":"Dig. Liver Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"G1706","DOI":"10.1152\/ajpgi.00573.2006","article-title":"T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis","volume":"292","author":"Ostanin","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/intimm\/dxh378","article-title":"Role of T-cell-associated lymphocyte function-associated antigen-1 in the pathogenesis of experimental colitis","volume":"18","author":"Pavlick","year":"2006","journal-title":"Int. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/labinvest.3700398","article-title":"Regulation of dextran sodium sulfate induced colitis by leukocyte beta 2 integrins","volume":"86","author":"Abdelbaqi","year":"2006","journal-title":"Lab. Investig. A J. Tech. Methods Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1007\/s10620-010-1525-6","article-title":"Efalizumab, a human monoclonal anti-CD11a antibody, in the treatment of moderate to severe Crohn\u2019s Disease: An open-label pilot study","volume":"56","author":"James","year":"2011","journal-title":"Dig. Dis. Sci."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/5\/354\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:33:12Z","timestamp":1760106792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/5\/354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["pathogens13050354"],"URL":"https:\/\/doi.org\/10.3390\/pathogens13050354","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]}}}